Article info
PDFExtended report
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
- Tsutomu Takeuchi, Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan; tsutake{at}saitama-med.ac.jp
Citation
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
Publication history
- Accepted July 14, 2007
- First published July 20, 2007.
Online issue publication
January 11, 2008
Article Versions
- Previous version (20 July 2007).
- Previous version (25 July 2007).
- Previous version (2 August 2007).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2008 BMJ Publishing Group and European League Against Rheumatism